Home|Journals|Articles by Year|Audio Abstracts
 

Original Article



The renal protective efficacy of ketamine vs. propofol vs. ketofol against renal ischemia / reperfusion injury: An experimental rat study

Sevda Akdeniz, Muhammet Bahaettin Ulu, Mustafa Bakirtas, Fikret Erdemir.




Abstract

The purpose of this study was to investigate the renal protective efficacy of propofol, ketamine, and ketofol in an ischemia/reperfusion injury (IRI) model experimentally induced in rats. Thirty-five male Sprague-Dawley rats were randomly assigned into five groups: sham (Group 1), control (Group 2), ketamine (Group 3), propofol (Group 4), and ketofol (Group 5). Following administration of intramuscular ketamine hydrochloride anesthesia, the left renal hilum was exposed to 60-minutes clamping. Ketamine (Group 3), propofol (Group 4), and ketofol (Group 5) were administered 15 min prior to reperfusion. After six hours of reperfusion, the left kidneys were harvested for histological injury scoring. Mean histopathology scores were 0.42±0.53 in group 1 (Sham), 2.97±0.21 in group 2 (Control), 2.68±0.15 in group 3 (Ketamine), 2.40±0.16 in group 4 (Propofol), and 2.51±0.22 in group 5 (Ketofol). The score in group 4 (Propofol) was significantly lower than those in groups 2 (control) and 3 (Ketamine) (P=.002 and P=.0120, respectively), but did not differ significantly from that in group 5 (Ketofol) (P=.347). The score in group 5 (Ketofol) was significantly lower compared to group 2 (control) (P=.006), but no significant difference was determined with Group 3 (Ketamine) (P=.137). No significant difference was also observed between Group 3 (Ketamine) and Group 2 (control) (P=.021). The study results indicated no superiority of ketofol over ketamine or propofol against renal IRI. However, the renal protective effect of propofol against IRI was greater than that of ketamine.

Key words: Propofol, ketofol, ketamine, ischemia reperfusion injury, kidney






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.